Prostaglandin EP Receptors and Their Roles in Mucosal Protection and Ulcer Healing in the Gastrointestinal Tract

Advances in Clinical Chemistry

Volumn 51, Issue C, 2010, Pages 121-144

  Takeuchi, Koji ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

EP receptor subtype; Function; Gastrointestinal tract; Mucosal protection; Prostaglandin E

Indexed keywords

BICARBONATE; INDOMETACIN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN EP3 RECEPTOR; PROSTANOID RECEPTOR EP1; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 3; PTGER1 PROTEIN, HUMAN; PTGER1 PROTEIN, MOUSE; PTGER3 PROTEIN, HUMAN; PTGER3 PROTEIN, MOUSE;

ANIMAL; BOOK; CELL PROTECTION; DRUG EFFECT; ESOPHAGUS; HUMAN; INTESTINE MUCOSA; METABOLISM; PATHOPHYSIOLOGY; PEPTIC ULCER; PHYSIOLOGY; STOMACH MUCOSA; WOUND HEALING; DRUG EFFECTS; TOXICITY;

ANIMALS; BICARBONATES; CYTOPROTECTION; DINOPROSTONE; ESOPHAGUS; GASTRIC MUCOSA; HUMANS; INDOMETHACIN; INTESTINAL MUCOSA; PEPTIC ULCER; RECEPTORS, PROSTAGLANDIN E; WOUND HEALING; RECEPTORS, PROSTAGLANDIN E, EP1 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP3 SUBTYPE;

EID: 77955897283     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2423(10)51005-9     Document Type: Book

References (67)

1. Miller T.A. Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am. J. Physiol. 1983, 245:G601-G623.
2. Robert A., Nezamis J.E., Lancaster C., Hanchar A.J. Cytoprotection by prostaglandins in rats: prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 1979, 77:433-443.
3. Coleman R.A., Kennedy I., Humphrey P.P.A., Bunce K., Lumley P. Prostanoids and their receptors. Comprehensive medicinal chemistry, membranes and receptors 1990, 643-714. Pergamon Press, Oxford. J.C. Emmett (Ed.).
4. Sugimoto Y., Namba T., Honda A., et al. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype. J. Biol. Chem. 1992, 267:6463-6466.
5. Watabe A., Sugimoto Y., Honda A., et al. Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor. J. Biol. Chem. 1993, 27:20175-20178.
6. Narumiya S., Sugimoto Y., Ushikubi F. Prostanoid receptors: structure, properties and functions. Physiol. Rev. 1999, 79:1193-1226.
7. Takeuchi K., Ukawa H., Kato S., et al. Impaired duodenal bicarbonate secretion and mucosal integrity in mice lacking prostaglandin E receptor subtype EP3. Gastroenterology 1999, 117:1128-1135.
8. Araki H., Yagi K., Suzuki K., Furukawa O., Takeuchi K. Roles of prostaglandin E receptor subtypes in cytoprotective action of prostaglandin E2 in rat stomachs. Alimental Pharmacol. Ther. 2000, 14(Suppl. 1):18-25.
9. Takeuchi K., Yagi K., Kato S., Ukawa H. Roles of prostaglandin E-receptor subtypes in gastric and duodenal bicarbonate secretion in rats. Gastroenterology 1997, 113:1553-1559.
10. Takeuchi K., Araki H., Komoike Y., Umeda M., Suzuki K. Adaptive gastric cytoprotection is mediated by prostaglandin EP1 receptors: a study using rats and knockout mice. J. Pharmacol. Exp. Ther. 2001, 297:1160-1165.
11. Suzuki K., Araki H., Mizoguchi H., Takeuchi K. E type prostaglandin inhibits indomethacin-induced gastric lesions in rats through EP1 receptors: importance of antigastric motility action. Digestion 2001, 63:92-101.
12. Kunikata T., Tanaka A., Miyazawa T., Kato S., Takeuchi K. 16, 16-dimetyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors. Dig. Dis. Sci. 2002, 47:894-904.
13. Robert A., Nezamis J.E., Lancaster C., Davis J.P., Field S.O., Hanchar A.J. Mild irritants prevent gastric necrosis through "adaptive cytoprotection" mediated by prostaglandins. Am. J. Physiol. 1983, 245:G113-G121.
14. Takeuchi K., Kato S., Ogawa Y., Takeeda M., Nakashima M., Matsumoto M. Facilitation by endogenous prostaglandins of capsaicin-induced gastric protection through EP2 and IP receptors. J. Pharmacol. Exp. Ther. 2003, 304:1055-1062.
15. Holzer P. Neural emergency system in the stomach. Gastroenterology 1998, 114:828-839.
16. Takeuchi K., Niida H., Matsumoto J., Ueshima K., Okabe S. Gastric motility changes in capsaicin-induced cytoprotection in the rat stomach. Jpn. J. Pharmacol. 1991, 55:147-155.
17. Uchida M., Yano S., Watanabe K. The role of capsaicin-sensitive afferent nerves in protective effect of capsaicin against absolute ethanol-induced gastric lesions in rats. Jpn. J. Pharmacol. 1991, 55:279-282.
18. 2 is attributable to sensitization of CRGP-containing sensory nerves. Gastroenterology 2001, 120:134-143.
19. Takeuchi K., Ueki S., Okabe S. Importance of gastric motility in the pathogenesis of indomethacin-induced gastric lesions in rats. Dig. Dis. Sci. 1986, 31:1114-1121.
20. Yokotani K., Okuma Y., Osumi Y. Inhibition of vagally mediated gastric acid secretion by activation of central prostanoid EP3 receptors in urethane-anesthetized rats. Br. J. Pharmacol. 1996, 117:653-656.
21. 2-stimulated mucus secretion by rabbit gastric epithelial cells. Biochem. Pharmacol. 1999, 58:1997-2002.
22. Ohno T., Katori M., Majima M., et al. Dilatation and constriction of rat gastric mucosal microvessels through prostaglandin EP2 and EP3 receptors. Aliment. Pharmacol. Ther. 1999, 13:1243-1250.
23. - secretion in stomach. J. Physiol. Pharmacol. 2006, 57:661-676.
24. 2 on gastric acid secretion through different EP receptor subtypes in the rat. Am. J. Physiol. 2005, 289:G64-G69.
25. Mersereau W.A., Hinchey E.J. Role of gastric mucosal folds in formation of focal ulcers in the rat. Surgery 1982, 91:150-155.
26. Takeuchi K., Matsumoto J., Ueshima K., Okabe S. Gastric motility changes in the cytoprotective action of N-ethyl-maleimide and capsaicin in the rat stomach. Frontier of Mucosal Immunology 1991, 581-584. Elsevier Science Publisher, New York. M. Tsuchiya (Ed.).
27. Takeuchi K., Ueshima K., Hironaka Y., Fujioka Y., Matsumoto J., Okabe S. Oxygen free radicals and lipid peroxidation in the pathogenesis of gastric mucosal lesions induced by indomethacin in rats. Digestion 1991, 49:175-184.
28. Okada M., Niida H., Takeuchi K., Okabe S. Role of prostaglandin deficiency in pathogenic Mechanism of gastric lesions induced by indomethacin in rats. Dig. Dis. Sci. 1989, 34:694-702.
29. 2α. Prostaglandins Leukot. Med. 1982, 8:287-300.
30. Ding M., Kinoshita Y., Kishi K., et al. Distribution of prostaglandin E receptors in the rat gastrointestinal tract. Prostaglandins 1997, 53:199-216.
31. Morimoto K., Sugimoto Y., Katsuyama M., et al. Cellular localization of mRNAs for prostaglandin E receptor subtypes in mouse gastrointestinal tract. Am. J. Physiol. 1997, 272:G681-G687.
32. Wallace J.L., Granger D.N. Pathogenesis of NSAID gastropathy; are neutrophils the culpris?. Trend Pharmacol. Sci. 1992, 3:129-131.
33. 2 and selective EP agonists on chemotaxis of human neutrophils. Br. J. Pharmacol. 1995, 116:2903-2908.
34. Melange R., Gentry C., Toseland N., Smith P.H., Fuller J. Neutropenia does not prevent etodolac- or indomethacin-induced gastrointestinal damage in the rat. Dig. Dis. Sci. 1995, 40:2694-2703.
35. Takeuchi K., Ueki S., Tanaka H. Endogenous prostaglandins in gastric alkaline response in the rat stomach after damage. Am. J. Physiol. 1986, 250:G842-G849.
36. Matsumoto J., Takeuchi K., Ueshima K., Okabe S. Role of capsaicin-sensitive afferent neurons in mucosal blood flow response of rat stomach induced by mild irritants. Dig. Dis. Sci. 1992, 37:1336-1344.
37. Hirata T., Ukawa H., Yamakuni H., Kato S., Takeuchi K. Cyclooxygenase isozymes in acute mucosal ulcerogenic and functional responses following barrier disruption in rat stomachs. Br. J. Pharmacol. 1997, 122:447-454.
38. Takeeda M., Yamato M., Kato S., Takeuchi K. Cyclooxygenase isozymes involved in adaptive functional responses in rat stomachs following barrier disruption. J. Pharmacol. Exp. Ther. 2003, 307:713-719.
39. Takeuchi K., Ogawa Y., Kagawa S., Ukawa H. Gastric ulcerogenic response following barrier disruption in knockout mice lacking prostaglandin EP1 receptors. Aliment. Pharmacol. Ther. 2002, 16:74-82.
40. Komoike Y., Nakashima M., Nakagiri A., Takeuchi K. Prostaglandin EP1 but not IP receptors involved in mucosal blood flow response of mouse stomachs following barrier disruption. Digestion 2003, 67:186-194.
41. Hunt R.H. Importance of pH control in the management of GERD. Arch. Intern. Med. 1999, 159:649-657.
42. 2 receptor antagonist, on acid reflux esophagitis in rats through capsaicin-sensitive afferent neurons. J. Pharmacol. Sci. 2003, 93:55-61.
43. Inatomi N., Nagaya H., Takami K., Shino A., Satoh H. Effects of a proton pump inhibitor, AG-1749 (lansoprazole), on reflux esophagitis and experimental ulcers in rats. Jpn. J. Pharmacol. 1991, 55:437-451.
44. 2 on a rat model of esophagitis mediated by EP1 receptors: relation to pepsin secretion. Digestion 2005, 72:109-118.
45. - transport by luminal acid in the frog in vitro. Am. J. Physiol. 1984, 246:G235-G246.
46. - transport: characteristics and proposed role in acidity regulation and mucosal protection. Am. J. Physiol. 1982, 242:G183-G193.
47. Hirata T., Ukawa H., Kato S., Takeuchi K. Effects of selective cyclooxygenase-2 inhibitors on acid-induced alkaline secretory and mucosal ulcerogenic responses in the rat duodenum. Life Sci. 1997, 61:1603-1611.
48. Takeuchi K., Kagawa S., Mimaki H., Kawauchi S. COX and NOS isozymes involved in duodenal bicabonate response induced by mucosal acidification in rats. Dig. Dis. Sci. 2002, 47:2116-2124.
49. Aoi M., Aihara E., Nakashima M., Takeuchi K. Participation of prostaglandin receptor EP4 subtype in duodenal bicarbonate secretion in rats. Am. J. Physiol. 2004, 287:G96-G103.
50. Hogan D.L., Yao B., Steinbach J.H., Isenberg J.I. The enteric nervous system modulates mammalian duodenal mucosal bicarbonate secretion. Gastroenterology 1993, 105:410-417.
51. Takeuchi K., Matsumoto J., Ueshima K., Okabe S. Role of capsaicin-sensitive afferent neurons in alkaline secretory response to luminal acid in the rat duodenum. Gastroenterology 1991, 101:954-961.
52. Takeuchi K., Furukawa O., Tanaka H., Okabe S. A new model of duodenal ulcers induced in rats by indomethacin plus histamine. Gastroenterology 1986, 90:636-645.
53. Aihara E., Nomura Y., Sasaki Y., Ise F., Kita K., Takeuchi K. Involvement of prostaglandin E receptor EP3 subtype in duodenal bicarbonate secretion in rats. Life Sci. 2007, 80:2446-2453.
54. Reuter B.K., Davies N.M., Wallace J.L. Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation. Gastroenterology 1997, 112:109-117.
55. Kunikata T., Araki H., Takeeda M., Kato S., Takeuchi K. Prostaglandin E prevents indomethacin-induced gastric and intestinal damage through different EP receptor subtypes. J. Physiol. Paris 2001, 95:157-163.
56. Boughton-Smith N., Evans S.M., Laszlo F., Whittle B.J.R., Moncada S. The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br. J. Pharmacol. 1993, 110:1189-1195.
57. Konaka A., Tanaka A., Kato S., Nishijima M., Takeuchi K. Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced intestinal lesions in rats. J. Physiol. Pharmacol. 1999, 50:25-38.
58. Tanaka A., Kunikata T., Konaka A., Kato S., Takeuchi K. Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats. J. Physiol. Pharmacol. 1999, 50:405-417.
59. 2 stimulates rat and human colonic mucin exoxcytosis via the EP4 receptor. Gastroenterology 1999, 117:1352-1362.
60. Bunce K.T., Spraggs C.F. Prostanoids stimulation of anion secretion in guinea-pig gastric and ileum mucosa is mediated by different receptors. Br. J. Pharmacol. 1990, 101:889-895.
61. Takeuchi K., Hase S., Mizoguchi H., Miyazawa T., Tanaka A. Protection by aspirin of indomethacin-induced small intestinal damage in rats: mediation by salicylic acid. J. Physiol. Paris 2001, 95:51-57.
62. Takeuchi K., Miyazawa T., Tanaka A., Kato S., Kunikata T. Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats. Digestion 2002, 66:30-41.
63. 2 accelerates the healing of gastric ulcers via EP4 receptors. Am. J. Physiol. 2007, 293:G788-G797.
64. Takeuchi K., Tanaka A., Kato S., Aihara E., Amagase K. Effect of CJ-42794, a selective antagonist of prostaglandin E receptor subtype 4, on ulcerogenic and healing responses in rat gastrointestinal mucosa. J. Pharmacol. Exp. Ther. 2007, 322:903-912.
65. Hatazawa R., Ohno R., Tanigami M., Tanaka A., Takeuchi K. Roles of endogenous prostaglandins and cyclooxygenase isozymes in healing of indomethacin-Induced small intestinal lesions in rats. J. Pharmacol. Exp. Ther. 2006, 318:691-699.
66. Takeuchi K., Tanigami M., Amagase K., Ochi A., Hatazawa R. Endogenous PGE2 accelerates healing of indomethacin-induced small intestinal lesions through up-regulation of VEGF expression via activation of EP4 receptors. J. Gastroentrol. Hepatol. 2010, 25:S67-S74.
67. Kabashima K., Saji T., Murata T., et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J. Clin. Invest. 2002, 109:883-893.